James Zidar
Interventional Cardiology · Raleigh, NCNPI 1205910189
Payments from drug & device makers
Across 296 payments — averaging $3844.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Contego Medical, Inc$732K
- Janssen Research & Development, LLC$103K
- Shockwave Medical, Inc$89K
- Abbott$80K
- CSL Behring$66K
- Medtronic$42K
- plus $25K from 23 others
Across 2 payments — averaging $2325.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Contego Medical, Inc$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Contego Medical, Inc | 26 | $732,149 |
| Janssen Research & Development, LLC | 26 | $103,499 |
| Shockwave Medical, Inc | 14 | $88,535 |
| Abbott | 57 | $80,242 |
| CSL Behring | 35 | $66,039 |
| Medtronic(2 entities) | 78 | $42,233 |
| Boston Scientific | 6 | $19,332 |
| Cordis US CORP. | 4 | $2,940 |
| Abiomed | 10 | $1,261 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $398 |
| Silk Road Medical, Inc. | 1 | $300 |
| Ablative Solutions, Inc. | 4 | $294 |
| Biotronik Inc. | 1 | $130 |
| Irhythm Technologies, Inc. | 3 | $86 |
| Bolton Medical Inc | 1 | $71 |
| Pfizer | 1 | $67 |
| Surmodics, Inc. | 1 | $57 |
| AstraZeneca | 3 | $53 |
| Angiodynamics, Inc. | 1 | $42 |
| Terumo Medical Corporation | 2 | $35 |
| Cardinal Health 200 LLC | 1 | $30 |
| Johnson & Johnson | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Amgen | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
| Gilead | 1 | $16 |
| Heartflow, Inc. | 1 | $13 |
| Sensible Medical Innovations Inc | 1 | $12 |
How this compares
$1,137,940 in reported general payments places this provider in the 90th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Raleigh
- Ravish SacharRaleigh$10.1M
- Willis WuRaleigh$671K
- Robert JobeRaleigh$490K
- Dwijesh PatelRaleigh$445K
- Joel SchneiderRaleigh$361K
- Mohit PasiRaleigh$117K
- Deepak PasiRaleigh$115K
- Andrew SampsonRaleigh$95K
- Islam OthmanRaleigh$74K
- William NewmanRaleigh$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.